Efficacy and safety of orforglipron in adults with body mass index of 27 to less than 30 kg/m2 and adiposity-related complications: A post hoc analysis of the ATTAIN-1 trial
Efficacy and safety of orforglipron in adults with body mass index of 27 to less than 30 kg/m2 and adiposity-related complications: A post hoc analysis of the ATTAIN-1 trial. // Obesity Pillars. – URL: https://www.sciencedirect.com/science/article/pii/S2667368126001026?dgcid=rss_sd_all
Efficacy and safety of orforglipron in adults with body mass index of 27 to less than 30 kg/m2 and adiposity-related complications: A post hoc analysis of the ATTAIN-1 trial. Obesity Pillars. https://www.sciencedirect.com/science/article/pii/S2667368126001026?dgcid=rss_sd_all
“Efficacy and safety of orforglipron in adults with body mass index of 27 to less than 30 kg/m2 and adiposity-related complications: A post hoc analysis of the ATTAIN-1 trial.” Obesity Pillars.
@article{article60724,
title = {Efficacy and safety of orforglipron in adults with body mass index of 27 to less than 30 kg/m2 and adiposity-related complications: A post hoc analysis of the ATTAIN-1 trial},
journal = {Obesity Pillars},
url = {https://www.sciencedirect.com/science/article/pii/S2667368126001026?dgcid=rss_sd_all}
}
European Journal of Clinical Nutrition, Published online: 20 November 2026; doi:10.1038/s41430-026-01857-5 Cyanocobalamin supplementation strategies in patients with Crohn’s disease and terminal ileal resection in clinical practice
European Journal of Clinical Nutrition, Published online: 20 November 2026; doi:10.1038/s41430-026-01855-7 Association of Mediterranean–DASH intervention for neurodegenerative delay (MIND) diet with cognition and total and...
ABSTRACT Food and land systems in the United Kingdom face growing challenges from climate change, biodiversity loss, and ongoing uncertainty regarding transitions to Net Zero. Nature‐based Solutions (NbS) offer a promising way to...